These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 33975684)

  • 1. The impact of recent next generation sequencing and the need for a new classification in gastric cancer.
    Businello G; Galuppini F; Fassan M
    Best Pract Res Clin Gastroenterol; 2021; 50-51():101730. PubMed ID: 33975684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational landscape of gastric cancer and clinical application of genomic profiling based on target next-generation sequencing.
    Cai H; Jing C; Chang X; Ding D; Han T; Yang J; Lu Z; Hu X; Liu Z; Wang J; Shang L; Wu S; Meng P; Lin L; Zhao J; Nie M; Yin K
    J Transl Med; 2019 Jun; 17(1):189. PubMed ID: 31164161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complementary utility of targeted next-generation sequencing and immunohistochemistry panels as a screening platform to select targeted therapy for advanced gastric cancer.
    Kim HS; Lee H; Shin SJ; Beom SH; Jung M; Bae S; Lee EY; Park KH; Choi YY; Son T; Kim HI; Cheong JH; Hyung WJ; Park JC; Shin SK; Lee SK; Lee YC; Koom WS; Lim JS; Chung HC; Noh SH; Rha SY; Kim H; Paik S
    Oncotarget; 2017 Jun; 8(24):38389-38398. PubMed ID: 28418920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deamination Effects in Formalin-Fixed, Paraffin-Embedded Tissue Samples in the Era of Precision Medicine.
    Kim S; Park C; Ji Y; Kim DG; Bae H; van Vrancken M; Kim DH; Kim KM
    J Mol Diagn; 2017 Jan; 19(1):137-146. PubMed ID: 27840062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance comparison of two commercial human whole-exome capture systems on formalin-fixed paraffin-embedded lung adenocarcinoma samples.
    Bonfiglio S; Vanni I; Rossella V; Truini A; Lazarevic D; Dal Bello MG; Alama A; Mora M; Rijavec E; Genova C; Cittaro D; Grossi F; Coco S
    BMC Cancer; 2016 Aug; 16(1):692. PubMed ID: 27578032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Next-Generation Sequencing in Castration-Resistant Prostate Cancer Treatment.
    Hovelson DH; Tomlins SA
    Cancer J; 2016; 22(5):357-361. PubMed ID: 27749331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRCA1/2 somatic mutation detection in formalin-fixed paraffin embedded tissue by next-generation sequencing in Korean ovarian cancer patients.
    Lee A; Kang J; Lee H; Lee YS; Choi YJ; Lee KH; Nistala GJ; Scafe CR; Choi J; Yoo J; Han M D E; Kim Y; Kim M
    Pathol Res Pract; 2019 Nov; 215(11):152595. PubMed ID: 31570282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next-generation Sequencing in the Management of Gastric and Esophageal Cancers.
    Rubinstein JC; Nicolson NG; Ahuja N
    Surg Clin North Am; 2019 Jun; 99(3):511-527. PubMed ID: 31047039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted Next Generation Sequencing as a Reliable Diagnostic Assay for the Detection of Somatic Mutations in Tumours Using Minimal DNA Amounts from Formalin Fixed Paraffin Embedded Material.
    de Leng WW; Gadellaa-van Hooijdonk CG; Barendregt-Smouter FA; Koudijs MJ; Nijman I; Hinrichs JW; Cuppen E; van Lieshout S; Loberg RD; de Jonge M; Voest EE; de Weger RA; Steeghs N; Langenberg MH; Sleijfer S; Willems SM; Lolkema MP
    PLoS One; 2016; 11(2):e0149405. PubMed ID: 26919633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter validation of cancer gene panel-based next-generation sequencing for translational research and molecular diagnostics.
    Hirsch B; Endris V; Lassmann S; Weichert W; Pfarr N; Schirmacher P; Kovaleva V; Werner M; Bonzheim I; Fend F; Sperveslage J; Kaulich K; Zacher A; Reifenberger G; Köhrer K; Stepanow S; Lerke S; Mayr T; Aust DE; Baretton G; Weidner S; Jung A; Kirchner T; Hansmann ML; Burbat L; von der Wall E; Dietel M; Hummel M
    Virchows Arch; 2018 Apr; 472(4):557-565. PubMed ID: 29374318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Robustness of Next Generation Sequencing on Older Formalin-Fixed Paraffin-Embedded Tissue.
    Carrick DM; Mehaffey MG; Sachs MC; Altekruse S; Camalier C; Chuaqui R; Cozen W; Das B; Hernandez BY; Lih CJ; Lynch CF; Makhlouf H; McGregor P; McShane LM; Phillips Rohan J; Walsh WD; Williams PM; Gillanders EM; Mechanic LE; Schully SD
    PLoS One; 2015; 10(7):e0127353. PubMed ID: 26222067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene mutations in gastric cancer: a review of recent next-generation sequencing studies.
    Lin Y; Wu Z; Guo W; Li J
    Tumour Biol; 2015 Sep; 36(10):7385-94. PubMed ID: 26364057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Actionable gene-based classification toward precision medicine in gastric cancer.
    Ichikawa H; Nagahashi M; Shimada Y; Hanyu T; Ishikawa T; Kameyama H; Kobayashi T; Sakata J; Yabusaki H; Nakagawa S; Sato N; Hirata Y; Kitagawa Y; Tanahashi T; Yoshida K; Nakanishi R; Oki E; Vuzman D; Lyle S; Takabe K; Ling Y; Okuda S; Akazawa K; Wakai T
    Genome Med; 2017 Oct; 9(1):93. PubMed ID: 29089060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Next-Generation Sequencing Using S1 Nuclease for Poor-Quality Formalin-Fixed, Paraffin-Embedded Tumor Specimens.
    Chun SM; Sung CO; Jeon H; Kim TI; Lee JY; Park H; Kim Y; Kim D; Jang SJ
    J Mol Diagn; 2018 Nov; 20(6):802-811. PubMed ID: 30055350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Right Treatment of the Right Patient: Integrating Genetic Profiling Into Clinical Decision Making in Advanced Gastric Cancer in Asia.
    Nakamura Y; Shitara K; Lee J
    Am Soc Clin Oncol Educ Book; 2021 Mar; 41():1-8. PubMed ID: 34010049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissection of gastric cancer heterogeneity for precision oncology.
    Ho SWT; Tan P
    Cancer Sci; 2019 Nov; 110(11):3405-3414. PubMed ID: 31495054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of cytocentrifugation supernatant fluid and formalin-fixed paraffin-embedded tissue for targeted next-generation sequencing.
    Janaki N; Harbhajanka A; Michael CW; Bomeisl P; Wasman J; Atchley M; Miskiewicz K; Alouani D; Sadri N
    Cancer Cytopathol; 2019 May; 127(5):297-305. PubMed ID: 30933438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of next-generation sequencing in the diagnosis of gastric cancer.
    Moradi N; Ohadian Moghadam S; Heidarzadeh S
    Scand J Gastroenterol; 2022 Jul; 57(7):842-855. PubMed ID: 35293278
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of early genetic changes in well-differentiated intramucosal gastric carcinoma by target deep sequencing.
    Yoshida T; Yamaguchi T; Maekawa S; Takano S; Kuno T; Tanaka K; Iwamoto F; Tsukui Y; Kobayashi S; Asakawa Y; Shindo H; Fukasawa M; Nakayama Y; Inoue T; Uetake T; Ohtaka M; Sato T; Mochizuki K; Enomoto N
    Gastric Cancer; 2019 Jul; 22(4):742-750. PubMed ID: 30756200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of next generation sequencing technology for somatic mutation detection in routine laboratory practice.
    Giardina T; Robinson C; Grieu-Iacopetta F; Millward M; Iacopetta B; Spagnolo D; Amanuel B
    Pathology; 2018 Jun; 50(4):389-401. PubMed ID: 29752127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.